Literature DB >> 1400866

Prostate visualization studies in males homozygous and heterozygous for 5 alpha-reductase deficiency.

J Imperato-McGinley1, T Gautier, K Zirinsky, T Hom, O Palomo, E Stein, E D Vaughan, J A Markisz, E Ramirez de Arellano, E Kazam.   

Abstract

Male pseudohermaphrodites with 5 alpha-reductase deficiency have ambiguous genitalia and nonpalpable prostates on rectal examination, suggesting the dihydrotestosterone dependency of these structures. To clearly delineate the status of the prostate, male pseudohermaphrodites with 5 alpha-reductase deficiency had transrectal sonography of the prostate performed, and the results were compared to that of age-matched male controls. In six male pseudohermaphrodites, magnetic resonance imaging studies of the prostate were also performed. Heterozygote fathers also had transrectal sonography of the prostate performed and the results compared to age-matched controls. The prostates of the male pseudohermaphrodites appeared as platelike soft tissue structures posterior to the urethra on both prostatic ultrasound and magnetic resonance imaging. Prostatic volume, as determined on prostatic ultrasound by two different methods, was significantly smaller (approximately one-tenth) than the volume of age-matched controls. Transurethral ultrasound guided biopsy of the prostate in two affected subjects revealed stromal tissue. These results correlate with undetectable prostate-specific antigen in affected subjects, suggesting atrophic epithelium or lack of epithelial differentiation. This study demonstrates the dihydrotestosterone dependence of the prostate for normal differentiation and growth. The presence of some prostatic tissue in the male pseudohermaphrodites may be due to the fact that there is a decrease and not an absence of 5 alpha-reductase activity, and/or that the increased level of testosterone in subjects with this condition partially compensates for the decreased level of dihydrotestosterone. There was no difference, however, in prostate size between heterozygous fathers and age-matched control males. The heterozygote fathers had dihydrotestosterone production sufficient for normal prostate growth and development.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400866     DOI: 10.1210/jcem.75.4.1400866

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  Molecular Basis of Steroid Action in the Prostate.

Authors:  Yuan-Shan Zhu
Journal:  Cellscience       Date:  2005-04-28

Review 2.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

Review 3.  Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia.

Authors:  Chris Olesovsky; Anil Kapoor
Journal:  Ther Adv Urol       Date:  2016-05-26

Review 4.  Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

Review 5.  The effect of 5α-reductase-2 deficiency on human fertility.

Authors:  Hey-Joo Kang; Julianne Imperato-McGinley; Yuan-Shan Zhu; Zev Rosenwaks
Journal:  Fertil Steril       Date:  2014-01-08       Impact factor: 7.329

Review 6.  Links between lower urinary tract symptoms, intermittent hypoxia and diabetes: Causes or cures?

Authors:  Lisa L Abler; Chad M Vezina
Journal:  Respir Physiol Neurobiol       Date:  2017-09-18       Impact factor: 1.931

7.  Cell-type-specific expression of rat steroid 5 alpha-reductase isozymes.

Authors:  D M Berman; D W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

Review 8.  Estrogen and androgen signaling in the pathogenesis of BPH.

Authors:  Clement K M Ho; Fouad K Habib
Journal:  Nat Rev Urol       Date:  2011-01       Impact factor: 14.432

Review 9.  Pre-receptor regulation of the androgen receptor.

Authors:  Trevor M Penning; Yi Jin; Tea Lanisnik Rizner; David R Bauman
Journal:  Mol Cell Endocrinol       Date:  2007-10-22       Impact factor: 4.102

Review 10.  The Prostate Cancer Prevention Trial: design, status, and promise.

Authors:  Ian M Thompson; Catherine Tangen; Phyllis Goodman
Journal:  World J Urol       Date:  2003-02-14       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.